Health Care: Drugs

Neuralstem Inc (CUR: NASDAQ)

$5.8 0.1 | 1.75%
06/28/17 - 10:06 AM ET
Company Profile
Price and Volume
Recent Price 5.70
52 Week High 6.60
52 Week Low 2.47
Avg. Daily Vol. (Mil) 0.10
Beta (3 year) 1.65
Share Related Items
Mkt Cap (Mil) 67.90
Shares Out (Mil) 11.91
Float (Mil) 8.99
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.30
Current Ratio 3.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.26
Valuation Ratios
Price Earnings n.a.
Price/Sales 4.18K
Price/Book 6.95
Price/Cash Flow -3.20
Per Share Data
Earnings -2.43
Sales 0.00
Book Value 0.82
Cash Flow -1.80
Business Summary
Neuralstem Inc is a biotechnology company. It is engaged in the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs.
General Information
20271 Goldenrod Lane
Germantown, MD 20876
Industry : Drugs
Sector: Health Care
Employees: 10
CEO: Mr. Richard J. Daly
Short Interest
Current Month (Mil) 0.94
Previous Month (Mil) 0.93
Short Interest Ratio (Days) 11.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -117.70
Return on Investments -225.30
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with CUR

Latest CUR Headlines from TheStreet

More Financial News for CUR

Press Releases for CUR

See All Press Releases

Partner Headlines for CUR

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter